Publication:
Cardiovascular disease and cardiovascular disease risk in HIV-positive populations in the Asian region

dc.contributor.authorRimke Bijkeren_US
dc.contributor.authorJun Yong Choien_US
dc.contributor.authorRossana Ditangcoen_US
dc.contributor.authorSasisopin Kiertiburanakulen_US
dc.contributor.authorMan Po Leeen_US
dc.contributor.authorSarawut Siwamogsathamen_US
dc.contributor.authorSanjay Pujarien_US
dc.contributor.authorJeremy Rossen_US
dc.contributor.authorChi Yuen Wongen_US
dc.contributor.authorWing Wai Wongen_US
dc.contributor.authorEvy Yunihastutien_US
dc.contributor.authorMatthew Lawen_US
dc.contributor.otherUniversity of New South Wales (UNSW) Australiaen_US
dc.contributor.otherYonsei University College of Medicineen_US
dc.contributor.otherGokilaen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherQueen Elizabeth Hospital Hong Kongen_US
dc.contributor.otherKing Chulalongkorn Memorial Hospital, Faculty of Medicine Chulalongkorn Universityen_US
dc.contributor.otherChulalongkorn Universityen_US
dc.contributor.otherInstitute of Infectious Diseasesen_US
dc.contributor.otherTREAT Asiaen_US
dc.contributor.otherVeterans General Hospital-Taipeien_US
dc.contributor.otherUniversity of Indonesia, RSUPN Dr. Cipto Mangunkusumoen_US
dc.date.accessioned2018-12-21T07:56:19Z
dc.date.accessioned2019-03-14T08:03:50Z
dc.date.available2018-12-21T07:56:19Z
dc.date.available2019-03-14T08:03:50Z
dc.date.issued2017-08-01en_US
dc.description.abstract© 2017 Bijker et al. Introduction: Cardiovascular diseases (CVD) are becoming more prevalent in HIV-infected populations as they age largely due to improved treatment outcomes. Assessment of CVD risk and CVD risk factors in HIV-positive populations has focused on high income settings, while there are limited studies evaluating CVD in HIV-positive populations in the Asian region. Materials and Methods: We provided an overview of the prevalence and incidence of CVD and its risk factors in adult HIV-positive populations, and of the strategies currently in place for CVD management in the Asian region. Results: Studies from the Asian region showed that CVD and CVD risk factors, such as dyslipidaemia, elevated blood glucose, obesity and smoking, are highly prevalent in HIV-positive populations. A number of studies suggested that HIV infection and antiretroviral therapy may contribute to increased CVD risk. National HIV treatment guidelines provide some directions regarding CVD risk prevention and management in the HIV-infected population, however, they are limited in number and scope. Conclusion: Development and consolidation of guidelines for integrated CVD and HIV care are essential to control the burden of CVD in HIVpositive populations. To inform guidelines, policies and practice in the Asian region, research should focus on exploring appropriate CVD risk screening strategies and estimating current and future CVD mortality and morbidity rates.en_US
dc.identifier.citationOpen AIDS Journal. Vol.11, (2017), 52-66en_US
dc.identifier.doi10.2174/1874613601711010052en_US
dc.identifier.issn18746136en_US
dc.identifier.other2-s2.0-85030779657en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/42802
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85030779657&origin=inwarden_US
dc.subjectImmunology and Microbiologyen_US
dc.titleCardiovascular disease and cardiovascular disease risk in HIV-positive populations in the Asian regionen_US
dc.typeReviewen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85030779657&origin=inwarden_US

Files

Collections